Global Specialty Generic Pharmaceuticals Market| Size, Share, Opportunity, Trends and Business Strategy Until 2025 | Teva Pharmaceuticals, Inc., Pfizer, Mylan, Valeant Pharmaceuticals and Sun Pharmaceuticals

AnalystView Market Insights has added the comprehensive study on global specialty generics pharmaceuticals market to its report store. The global specialty generic pharmaceuticals market is expected to grow at the growth rate of 20.8% to reach USD 169.8 billion by 2025. The global study presents a comprehensive study of generic pharmaceuticals and scans industry progression & opportunity assessment over the past few years and projected growth in coming years until 2025. The report analyzes the industry in terms of types, indication, end-use and geography. This comprehensive study reveals the market estimate numbers for different market segments. Along with that, the study covers qualitative insights, strategic benchmarking and thorough competitive landscaping in the report spreading over 102 pages.
Over the past few years have shown a shift in the focus of pharmaceutical firms from branded drugs to specialty generics owing to several products going off-patent and high impact of the loss of exclusivity. Branded specialty generics are facing increasing patent expiration; thus they are expected to face competition from generic versions in the near future. For example, during the forecast period, approximately 72 branded specialty injectables are expected to lose patent protection in the U.S. only. Such factors will boost the demand and utilization of specialty generic pharmaceuticals among end-users, leading to driving the market growth.

Favorable government initiatives are also expected to boost the market growth to great extent. In 2016, the U.S. FDA approved 73 ANDAs and it was found that approximately 65% of the approved ANDAs were applied by major generic competitors. For instance, ANDA for mycophenolate mofetil hydrochloride injection (500mg/vial) was filed by Par Sterile Products LLC, which received approval in 2016. The patent of its branded version, CellCept, expired in 2009. In addition, as per the database of the U.S.FDA, 46 drugs received approval in 2017, this shows the widening scope for growth of specialty injectable generics market. Other factors such as demand for low-cost therapeutics and growing awareness level for generic pharmaceuticals will spur the market growth to some extent.

To request free sample copy of Specialty Generic Pharmaceuticals Market @
www.analystviewmarketinsights.com/request_sample/av101/

However, a strict regulatory guideline for generic therapeutics hampers the market growth. For example, the presence of a stringent regulatory process has led to the delay in the launch of specialty injectable generics significantly. The regulatory bodies in the U.S. are increasingly focusing on thorough inspections of these drugs, thereby leading to slow approval procedure.
Also, a wide gap in adherence to Good Manufacturing Practices (GMP) protocol creates a significant rise in quality issues, and demands rapid integration & streamlining of operations and strict actions by FDA. On the other hand, some of the investments in maintaining quality standards are not justified by margins offered by various government-run programs, such as Medicare, which has led to rationalization of product portfolio for several players.

The global specialty generic pharmaceutic market is categorized in terms of injectables, oral drugs, and others. Among which, oral and self-injectable specialty therapeutics has been increasing owing to the technological advancements. Injectable generic therapeutics is considered to be the fast catching market segment, growing constantly over the forecast period. Injectable generics for oncology treatment is widely in demand across the globe.

Based on the indication, the market is divided as Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, and Others. The end-user segment is covered under Specialty pharmacies, Retail pharmacies, and Hospital pharmacies. Specialty pharmacies accounted for the largest share of the global market, captured around USD 21.6 billion in 2016 and are expected to dominate the market over the forecast period.
Major market players are consistently striving to achieve consolidation in the industry by deploying extensive collaborative strategies and mergers & acquisitions to sustain the competition. Leading players such as Sandoz; Teva Pharmaceuticals, Inc., Valeant Pharmaceuticals; Sun Pharmaceuticals; Mylan N.V.; Pfizer, Inc.; and other are present in this market. These market leaders are involved in the establishment of extensive distribution systems as well as increasingly involving in mergers & acquisitions to capture a larger share of the market.

Browse full report with in-depth ToC on “Specialty Generic Pharmaceuticals Market, By Types, By Indication, By End Use, and Geography– Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” at
www.analystviewmarketinsights.com/report-highlight-specialty-generic-pharmaceutical-market-101/

Scope of the Report:
Market, by Types: Injectable, Oral and others;

Market, by Indication: Oncology, Inflammatory, Multiple sclerosis and Hepatitis C;

Market, by End Use: Specialty Pharmacies, Retail Pharmacies and Hospital Pharmacies;

Market, by Region: North America, Europe, Asia Pacific, Latin America, Middle East and Africa and Rest of the World; Market, by Country: U.S., Canada, Germany, France, India, and China;

Global Specialty Generic Pharmaceuticals Market Top Key Players:
- Teva Pharmaceuticals, Inc.
- Valeant Pharmaceuticals
- Sun Pharmaceuticals
- Mylan N.V.
- Pfizer, Inc.
- Novartis AG

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Research Methodology:
- Preliminary Data Mining: Secondary Research, Paid Databases, Primary Research
- Data Synthesis & Analysis: Top-Down Approach, Bottom-Up Approach, Supply Side and Demand Side
- Market Formulation: Market Dynamics, Total Addressable Market and Machine Learning Technique
- Data Verification: Quality Assurance and Reach a Conclusion

Find out more by getting in touch: https://www.analystviewmarketinsights.com/get-in-touch/

About AnalystView Market Insights
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact us for more details:
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.